Evaluating anti-tumor activity of the human anti-PD-1 antibody pembrolizumab using humanized mouse models

被引：0
|
作者：
Linn, Douglas E.
Cristescu, Razvan
Ray, Kallol
Zhang, Shuli
Dhandapani, Sripriya
Kaliyaperumal, Sarav
Yearley, Jennifer H.
Long, Brian J.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1657
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1657
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Enhanced anti-tumor response elicited by a novel oncolytic HSV-1 engineered with an anti-PD-1 antibody
    Tian, Chao
    Liu, Jiajia
    Zhou, Hua
    Li, Jingfeng
    Sun, Chunyang
    Zhu, Wei
    Yin, Yuxin
    Li, Xiaopeng
    CANCER LETTERS, 2021, 518 : 49 - 58
  • [22] Neutralizing anti-FGFR1 antibody as a combined partner of anti-PD-1 antibodies in tumor models
    Tsimafeyeu, I.
    Smith, J.
    Yin, W.
    Fanelli, A.
    Olshanskaya, A.
    Khochenkov, D. A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1315 - S1315
  • [23] Activity of Anti-PD-1 in Murine Tumor Models: Role of "Host" PD-L1 and Synergistic Effect of Anti-PD-1 and Anti-CTLA-4
    Korman, Alan
    Chen, Bing
    Wang, Changyu
    Wu, Linda
    Cardarelli, Pina
    Selby, Mark
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [24] Caffeine-enhanced anti-tumor activity of anti-PD1 monoclonal antibody
    Tej, Gullanki Naga Venkata Charan
    Neogi, Kaushik
    Nayak, Prasanta Kumar
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 77
  • [25] Development of a novel humanized mouse model for improved evaluation of in vivo anti-cancer effects of anti-PD-1 antibody
    Katano, Ikumi
    Hanazawa, Asami
    Otsuka, Iyo
    Yamaguchi, Takuya
    Mochizuki, Misa
    Kawai, Kenji
    Ito, Ryoji
    Goto, Motohito
    Kagawa, Takahiro
    Takahashi, Takeshi
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [26] Development of a novel humanized mouse model for improved evaluation of in vivo anti-cancer effects of anti-PD-1 antibody
    Ikumi Katano
    Asami Hanazawa
    Iyo Otsuka
    Takuya Yamaguchi
    Misa Mochizuki
    Kenji Kawai
    Ryoji Ito
    Motohito Goto
    Takahiro Kagawa
    Takeshi Takahashi
    Scientific Reports, 11
  • [27] Tumor suppressive effect of anti-PD-1 antibody against angiosarcoma in a mouse model
    Sekiguchi, Akiko
    Ishikawa, Mai
    Fujiwara, Chisako
    Inoue, Yuta
    Yamazaki, Sahori
    Uchiyama, Akihiko
    Motegi, Sei-ichiro
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2022, 105 (01) : 58 - 60
  • [28] Antitumor activity of liposomal formulation of eribulin combined with anti-human PD-1 antibody using hPBMC-humanized mouse models
    Niwa, Yuki
    Semba, Taro
    CANCER RESEARCH, 2023, 83 (07)
  • [29] Preclinical combination strategies to enhance the efficacy of the anti-PD-1 antibody pembrolizumab
    Pinheiro, Elaine M.
    Hinton, Marlene
    Mangadu, Ruban
    Cai, Mingmei
    Phan, Uyen
    Nebozhyn, Michael
    Hirsch, Heather
    Loboda, Andrey
    Javaid, Sarah
    Wang, Yaolin
    Sriram, Venkataraman
    Phillips, Joseph H.
    McClanahan, Tern
    Long, Brian
    CANCER RESEARCH, 2016, 76
  • [30] Therapy of the metastatic Merkel Cell Carcinoma with the Anti-PD-1 Antibody Pembrolizumab
    Meier, K.
    Wilhelmi, J.
    Lomberg, D.
    Spaenkuch, I
    Scheu, A.
    Leiter, U.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 171 - 171
12345